Literature DB >> 29959265

Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions.

Jeremy F Strain1, Robert X Smith1, Helen Beaumont1, Catherine M Roe1, Brian A Gordon1, Shruti Mishra1, Babatunde Adeyemo1, Jon J Christensen1, Yi Su1, John C Morris1, Tammie L S Benzinger1, Beau M Ances2.   

Abstract

OBJECTIVE: White matter (WM) projections were assessed from Alzheimer disease (AD) gray matter regions associated with β-amyloid (Aβ), tau, or neurodegeneration to ascertain relationship between WM structural integrity with Aβ and/or tau deposition.
METHODS: Participants underwent diffusion tensor imaging (DTI), PET Aβ ([18F]AV-45 [florbetapir]), and PET tau ([18F]AV-1451 [flortaucipir]) imaging. Probabilistic WM summary and individual tracts were created from either a composite or individual gray matter seed regions derived from Aβ, tau, and neurodegeneration. Linear regressions were performed for Aβ, age, tau and WM hyperintensities (WMH) to predict mean diffusivity (MD) or fractional anisotropy (FA) from the corresponding WM summaries or tracts.
RESULTS: Our cohort was composed of 59 cognitively normal participants and 10 cognitively impaired individuals. Aβ was not associated with DTI metrics in WM summary or individual tracts. Age and WMH strongly predicted MD and FA in several WM regions, with tau a significant predictor of MD only in the anterior temporal WM.
CONCLUSION: Tau, not Aβ, was associated with changes in anterior temporal WM integrity. WMH, a proxy for vascular damage, was strongly associated with axonal damage, but tau independently contributed to the model, suggesting an additional degenerative mechanism within tracts projecting from regions vulnerable to AD pathology. WM decline was associated with early tau accumulation, and further decline may reflect tau propagation in more advanced stages of AD.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29959265      PMCID: PMC6070383          DOI: 10.1212/WNL.0000000000005864

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease.

Authors:  Claire E Sexton; Ukwuori G Kalu; Nicola Filippini; Clare E Mackay; Klaus P Ebmeier
Journal:  Neurobiol Aging       Date:  2010-07-08       Impact factor: 4.673

2.  [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Authors:  M A Mintun; G N Larossa; Y I Sheline; C S Dence; S Y Lee; R H Mach; W E Klunk; C A Mathis; S T DeKosky; J C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  White Matter Changes and Confrontation Naming in Retired Aging National Football League Athletes.

Authors:  Jeremy F Strain; Nyaz Didehbani; Jeffrey Spence; Heather Conover; Elizabeth K Bartz; Sethesh Mansinghani; Myrtle K Jeroudi; Neena K Rao; Lindy M Fields; Michael A Kraut; C Munro Cullum; John Hart; Kyle B Womack
Journal:  J Neurotrauma       Date:  2016-07-06       Impact factor: 5.269

5.  White matter integrity in brain networks relevant to anxiety and depression: evidence from the human connectome project dataset.

Authors:  Nele A J De Witte; Sven C Mueller
Journal:  Brain Imaging Behav       Date:  2017-12       Impact factor: 3.978

6.  Partial volume correction in quantitative amyloid imaging.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Daniel S Marcus; Beau M Ances; Randall J Bateman; Nigel J Cairns; Patricia Aldea; Lisa Cash; Jon J Christensen; Karl Friedrichsen; Russ C Hornbeck; Angela M Farrar; Christopher J Owen; Richard Mayeux; Adam M Brickman; William Klunk; Julie C Price; Paul M Thompson; Bernadino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Peter R Schofield; Virginia Buckles; John C Morris; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2014-12-05       Impact factor: 6.556

Review 7.  Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Authors:  Harald Hampel; Katharina Bürger; Stefan J Teipel; Arun L W Bokde; Henrik Zetterberg; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

Review 8.  Measuring Cortical Connectivity in Alzheimer's Disease as a Brain Neural Network Pathology: Toward Clinical Applications.

Authors:  Stefan Teipel; Michel J Grothe; Juan Zhou; Jorge Sepulcre; Martin Dyrba; Christian Sorg; Claudio Babiloni
Journal:  J Int Neuropsychol Soc       Date:  2016-02       Impact factor: 2.892

9.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.

Authors:  Matthew R Brier; Brian Gordon; Karl Friedrichsen; John McCarthy; Ari Stern; Jon Christensen; Christopher Owen; Patricia Aldea; Yi Su; Jason Hassenstab; Nigel J Cairns; David M Holtzman; Anne M Fagan; John C Morris; Tammie L S Benzinger; Beau M Ances
Journal:  Sci Transl Med       Date:  2016-05-11       Impact factor: 17.956

10.  The minimal preprocessing pipelines for the Human Connectome Project.

Authors:  Matthew F Glasser; Stamatios N Sotiropoulos; J Anthony Wilson; Timothy S Coalson; Bruce Fischl; Jesper L Andersson; Junqian Xu; Saad Jbabdi; Matthew Webster; Jonathan R Polimeni; David C Van Essen; Mark Jenkinson
Journal:  Neuroimage       Date:  2013-05-11       Impact factor: 6.556

View more
  26 in total

Review 1.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

2.  Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Authors:  Brian A Gordon; Tyler M Blazey; Jon Christensen; Aylin Dincer; Shaney Flores; Sarah Keefe; Charles Chen; Yi Su; Eric M McDade; Guoqiao Wang; Yan Li; Jason Hassenstab; Andrew Aschenbrenner; Russ Hornbeck; Clifford R Jack; Beau M Ances; Sarah B Berman; Jared R Brosch; Douglas Galasko; Serge Gauthier; James J Lah; Mario Masellis; Christopher H van Dyck; Mark A Mintun; Gregory Klein; Smiljana Ristic; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

3.  Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progression.

Authors:  Fardin Nabizadeh; Mahsa Pourhamzeh; Saghar Khani; Ayda Rezaei; Fatemeh Ranjbaran; Niloofar Deravi
Journal:  Metab Brain Dis       Date:  2022-01-11       Impact factor: 3.584

4.  White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.

Authors:  Dorothee Schoemaker; Maria Clara Zanon Zotin; Kewei Chen; Kay C Igwe; Clara Vila-Castelar; Jairo Martinez; Ana Baena; Joshua T Fox-Fuller; Francisco Lopera; Eric M Reiman; Adam M Brickman; Yakeel T Quiroz
Journal:  Alzheimers Res Ther       Date:  2022-06-29       Impact factor: 8.823

Review 5.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

6.  Quantitative measurement of macromolecular tissue properties in white and gray matter in healthy aging and amnestic MCI.

Authors:  Elveda Gozdas; Hannah Fingerhut; Hua Wu; Jennifer L Bruno; Lauren Dacorro; Booil Jo; Ruth O'Hara; Allan L Reiss; S M Hadi Hosseini
Journal:  Neuroimage       Date:  2021-05-15       Impact factor: 7.400

Review 7.  Connectomics and molecular imaging in neurodegeneration.

Authors:  Gérard N Bischof; Michael Ewers; Nicolai Franzmeier; Michel J Grothe; Merle Hoenig; Ece Kocagoncu; Julia Neitzel; James B Rowe; Antonio Strafella; Alexander Drzezga; Thilo van Eimeren
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-11       Impact factor: 10.057

8.  Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease.

Authors:  Stephanie A Schultz; Jeremy F Strain; Adedamola Adedokun; Qing Wang; Oliver Preische; Jens Kuhle; Shaney Flores; Sarah Keefe; Aylin Dincer; Beau M Ances; Sarah B Berman; Adam M Brickman; David M Cash; Jasmeer Chhatwal; Carlos Cruchaga; Michael Ewers; Nick N Fox; Bernardino Ghetti; Alison Goate; Neill R Graff-Radford; Jason J Hassenstab; Russ Hornbeck; Clifford Jack; Keith Johnson; Nelly Joseph-Mathurin; Celeste M Karch; Robert A Koeppe; Athene K W Lee; Johannes Levin; Colin Masters; Eric McDade; Richard J Perrin; Christopher C Rowe; Stephen Salloway; Andrew J Saykin; Reisa Sperling; Yi Su; Victor L Villemagne; Jonathan Vöglein; Michael Weiner; Chengjie Xiong; Anne M Fagan; John C Morris; Randall J Bateman; Tammie L S Benzinger; Mathias Jucker; Brian A Gordon
Journal:  Neurobiol Dis       Date:  2020-06-06       Impact factor: 5.996

9.  Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease.

Authors:  Farshid Sepehrband; Ryan P Cabeen; Giuseppe Barisano; Nasim Sheikh-Bahaei; Jeiran Choupan; Meng Law; Arthur W Toga
Journal:  Alzheimers Dement (Amst)       Date:  2019-04-22

10.  Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients.

Authors:  Sofia Finsterwalder; Naomi Vlegels; Benno Gesierich; Miguel Á Araque Caballero; Nick A Weaver; Nicolai Franzmeier; Marios K Georgakis; Marek J Konieczny; Huiberdina L Koek; Celeste M Karch; Neill R Graff-Radford; Stephen Salloway; Hwamee Oh; Ricardo F Allegri; Jasmeer P Chhatwal; Frank Jessen; Emrah Düzel; Laura Dobisch; Coraline Metzger; Oliver Peters; Enise I Incesoy; Josef Priller; Eike J Spruth; Anja Schneider; Klaus Fließbach; Katharina Buerger; Daniel Janowitz; Stefan J Teipel; Ingo Kilimann; Christoph Laske; Martina Buchmann; Michael T Heneka; Frederic Brosseron; Annika Spottke; Nina Roy; Birgit Ertl-Wagner; Klaus Scheffler; Sang Won Seo; Yeshin Kim; Duk L Na; Hee Jin Kim; Hyemin Jang; Michael Ewers; Johannes Levin; Reinhold Schmidt; Ofer Pasternak; Martin Dichgans; Geert Jan Biessels; Marco Duering
Journal:  Alzheimers Dement       Date:  2020-08-18       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.